Microdosing Ozempic and Other GLP-1 Medications in Toronto
Physician-directed by Dr. Shari Caplan, MD · VitalityMD Toronto · In clinic or virtually
Microdosing at VitalityMD means starting a GLP-1 medication, such as Ozempic (semaglutide) or Mounjaro (tirzepatide), at a much lower dose, given differently than the standard way, and combining it with a functional medicine approach that reduces inflammation, replaces nutrient deficiencies and supports detox. At VitalityMD, we use low-dose GLP-1s not only for weight, but for their wider effects on inflammation, cravings and food noise, metabolic health and brain health. Every plan is medically supervised, with comprehensive baseline testing and follow-up every 3 months.
Jump to: How it works · What it’s used for · Which medications · Safety and side effects · FAQ
What Is Microdosing?
Treatment begins at much lower dosing and is administered differently than the standard way. Many people think microdosing is just using low doses, but it is not. Microdosing incorporates a functional medicine approach: we reduce inflammation, replace nutrient deficiencies, work on detox and more, which makes the micro dose more effective, with fewer side effects.
Ozempic (semaglutide) is best known for managing type 2 diabetes, but GLP-1 medications act on receptors throughout the body, which is why they are now used for much more than blood sugar and weight.
GLP-1 (glucagon-like peptide-1) is a hormone produced in the gut that helps regulate blood sugar and appetite. When you eat, GLP-1 stimulates insulin production and slows digestion, helping you feel full longer. GLP-1 medications mimic these actions, signalling to your brain that you’re no longer hungry, stabilizing blood sugar and reducing cravings.
How Does Microdosing Work?
Instead of starting at a standard dose, microdosing lets your body adjust gradually. You still benefit from the medication’s effects on appetite, blood sugar and inflammation, and lower doses are often easier to tolerate, which makes it easier to stay on treatment long term.
Beyond Weight Loss: What GLP-1 Medications Do in the Body
GLP-1 receptors are found throughout the body, including the brain, heart, kidneys, liver, pancreas, fat tissue and muscle. That is why research on GLP-1 medications reaches well beyond weight:
- Heart: in a large trial of adults with overweight and existing heart disease, semaglutide lowered the risk of heart attack, stroke and cardiovascular death by about 20%.
- Kidneys: in people with type 2 diabetes and chronic kidney disease, semaglutide slowed kidney decline and reduced protein in the urine.
- Liver: semaglutide has been shown to reduce liver fat and improve fatty liver disease.
- Inflammatory and other conditions being studied include MCAS, Alzheimer’s prevention and treatment, endometriosis, PCOS, psoriasis, rheumatoid arthritis and lung inflammation such as asthma and COPD.
Cravings and addiction. By regulating appetite, GLP-1 medications can help reduce cravings for high-calorie foods, potentially helping with food addiction or binge eating. There is limited evidence on their direct effect on alcohol and drug use, but improving metabolic health and reducing cravings may indirectly support healthier behaviour patterns.
Neuroinflammation and Alzheimer’s disease. GLP-1 medications may have neuroprotective properties that reduce inflammation in the brain and could lower the risk of neurodegenerative diseases like Alzheimer’s. They may improve cognitive function, but more research is needed to fully understand these effects.
GLP-1 medications such as semaglutide (Ozempic/Wegovy), liraglutide (Saxenda/Victoza) and tirzepatide (Mounjaro/Zepbound, a dual GIP/GLP-1 medication) are being studied for a growing range of conditions beyond type 2 diabetes, weight management and heart and kidney risk reduction. Approval varies by country and by drug, and a medication may be approved for one use and prescribed off-label for another.
| Condition | What research suggests |
|---|---|
| Polycystic ovary syndrome (PCOS) | May improve insulin resistance, weight, cycle regularity, androgen-related symptoms and possibly fertility |
| Alcohol and other substance use disorders | May reduce cravings, reward-driven consumption or alcohol intake |
| Alzheimer’s disease and cognitive decline | Studied for neuroinflammation, brain insulin signalling and possible neuroprotection |
| Parkinson’s disease | Studied for effects on neuronal inflammation and degeneration |
| Knee osteoarthritis | Semaglutide reduced body weight and knee pain in people with obesity and osteoarthritis |
| Idiopathic intracranial hypertension (IIH) | Early studies suggest lower intracranial pressure and fewer headaches |
| Fatty liver disease (MASLD/MASH) | Can reduce liver fat and improve some markers of liver inflammation |
| Chronic kidney disease without diabetes | May slow kidney-function decline |
| Heart failure with preserved ejection fraction (HFpEF) | May improve symptoms and exercise capacity in obesity-related HFpEF |
| Psoriasis and hidradenitis suppurativa | Studied for improvements in inflammatory skin disease |
| Rheumatoid arthritis and other inflammatory disorders | Early research suggests a possible lower inflammatory burden |
| Asthma and COPD | Studied for fewer flare-ups through better metabolic health and lower inflammation |
| Short bowel syndrome and intestinal disorders | Studied for effects on intestinal transit, fluid absorption and nutrient handling |
| Neuropathic pain and diabetic neuropathy | Effects on inflammation and nerve health being explored |
| Bone health and osteoporosis | Studied for effects on bone density and fracture risk |
| Eating-related disorders and compulsive behaviours | Interest in reduced food preoccupation, cravings and binge-type eating |
Other research areas include obstructive sleep apnea (tirzepatide is approved for this in eligible adults with obesity in the US) and COVID-19 and other inflammatory outcomes, where observational findings have prompted more research.
Important: promising research does not mean a medication has been shown to treat the underlying condition directly. Some benefits may come mainly from weight loss or better blood sugar control. GLP-1 medications can cause gastrointestinal side effects and carry other important risks, so off-label prescribing requires an individualized assessment. At VitalityMD we have this discussion regularly and have found many patients benefit from a GLP-1 for issues unrelated to weight. Often we don’t want these patients to lose weight, which requires expertise and close follow-up.
For more, read Dr. Caplan’s article GLP-1 Benefits Beyond Weight Loss.
Benefits of Microdosing for Weight and Metabolism
- Appetite and portion control. By slowing digestion, GLP-1 medications help you feel fuller for longer, making it easier to eat smaller portions. This is especially helpful for emotional or binge eating.
- Gradual, sustainable weight loss. Steady loss is easier on your body than crash dieting. Some patients use microdosing for its other benefits without aiming to lose weight; at VitalityMD the dose is matched to your medical condition and goals.
- Better blood sugar regulation. Even without diabetes, microdosing can help stabilize blood sugar, which means more consistent energy and fewer sugar cravings. It can also improve HbA1c and cholesterol.
- Fewer side effects. Nausea, vomiting, diarrhea and constipation are less likely and less intense at lower doses.
Which GLP-1 Medications Are Used?
GLP-1 medications are a class of drugs, and new options continue to arrive:
- Semaglutide: Ozempic and Wegovy (weekly injections), Rybelsus (daily pill)
- Tirzepatide: Mounjaro (weekly injection), which acts on both GLP-1 and GIP receptors
At present, VitalityMD mostly uses Mounjaro and Ozempic. Your VitalityMD provider chooses the medication and dose based on your health history, goals, how you respond and coverage.
How Microdosing Works at VitalityMD, Step by Step
VitalityMD is proud to be the first clinic in Toronto, and possibly in Canada, to offer a GLP-1 microdosing protocol.
- Consultation and baseline testing. Dr. Caplan or one of her functional medicine trained nurses or PA will review your health history, medications and goals, and do comprehensive blood panels, including metabolic markers, inflammatory markers and hormones, and look for nutrient deficiencies.
- Microdosing. Treatment begins at much lower dosing and is administered differently than the standard way, combined with a functional medicine approach to inflammation, nutrient deficiencies and detox.
- Slow, individual adjustments. The dose is adjusted gradually based on how you feel, your appetite, side effects and progress, not on a fixed schedule.
- Ongoing monitoring. Follow-up visits track weight, body composition, blood work and how you’re tolerating treatment. Blood work and 3D body scans are done at baseline and every 3 months, or sooner if needed.
- A long-term plan. Together you decide whether to continue at a maintenance dose, adjust or taper, with nutrition and strength training built in throughout.
Microdosing is a prescription treatment and should only be done under a physician’s care. Never adjust or split doses on your own.
Is Microdosing Safe?
Microdosing is generally well tolerated, especially when done under medical supervision. The lower dose reduces the risk of side effects, but it’s still important to work with a healthcare provider to make sure you’re on the right dose.
Incorrect dosing can lead to complications such as low blood sugar (hypoglycemia), especially if you’re taking other medications. That’s why VitalityMD monitors your progress and adjusts treatment as needed.
Side Effects
The most common side effects of GLP-1 medications are nausea, vomiting, diarrhea and constipation. They are less likely and less severe at lower doses. If you do experience side effects, tell your provider; they can help you manage symptoms and adjust your plan.
Who Is a Good Candidate?
Microdosing is not just for people with diabetes. At VitalityMD it is prescribed off-label for people with obesity, insulin resistance, metabolic syndrome, perimenopause and menopause, and neuroinflammatory conditions. People with cravings, binge eating, autoimmune or other metabolic concerns may also benefit. A consultation determines whether it’s right for you.
Protecting Your Muscle While You Lose Weight
Typically, 20 to 30% of the weight you lose is muscle, and with rapid weight loss it can be 25 to 40%. That can slow your metabolism, stall further weight loss and make it harder to keep the weight off. We now know that muscle is the currency of longevity. Without it, sarcopenia and frailty become inevitable.
- Eat enough protein at every meal: chicken, fish, eggs, Greek yogurt, tofu or legumes
- Strength train at least two to three times a week
- Add fibre and water to support digestion, especially if your appetite is low
But even then, that may not be enough. Many VitalityMD patients add Emsculpt NEO, which uses HIFEM (high-intensity focused electromagnetic) energy and RF heat to build muscle while reducing fat. Four sessions of Emsculpt NEO are like 16 weeks of intense exercise. It builds about 25% more muscle, which helps raise your metabolic rate and make you more insulin sensitive. Dr. Jonathan Schoeff, a US-based longevity expert and doctor to many professional athletes, feels that treating three body areas can cause weight loss on its own because of these benefits.
Lifestyle Changes to Maximize Results
GLP-1 medications work best alongside healthy habits:
- Balanced diet: enough protein, healthy fats, whole grains, fruits and vegetables; avoid ultra-processed foods high in sugar and unhealthy fats.
- Regular exercise: strength training to protect muscle and metabolism, plus cardio; aim for at least 150 minutes of moderate activity per week.
- Sleep and stress management: 7 to 9 hours of sleep and stress-reduction practices like meditation, yoga or deep breathing.
Why Medical Supervision Is Essential
Self-administering GLP-1 medications without medical guidance can be dangerous, and they should never be used on their own. They work best as part of a complete plan that includes lifestyle changes and regular monitoring. At VitalityMD you receive the correct dose and ongoing monitoring to minimize risks and maximize results.
Frequently Asked Questions
Some people notice changes within days or weeks, while others take a few months. Consistency and lifestyle changes are key.
Yes. Many providers prescribe GLP-1 medications off-label for weight and other health concerns in people without diabetes, always under medical supervision.
Not necessarily. They serve different goals. Standard doses produce faster, larger weight loss for some people; microdosing aims for the broader benefits with fewer side effects and is better suited to longer-term use. Your VitalityMD provider will recommend what fits your goals.
Ozempic and Wegovy are both injectable semaglutide, a GLP-1 medication. Rybelsus is semaglutide in pill form. Mounjaro is tirzepatide, which acts on both GLP-1 and GIP receptors. The right choice depends on your health history, goals and coverage.
In clinical trials, most people regained a large share of the weight they lost within a year of stopping a GLP-1 medication. That’s why VitalityMD won’t let patients use a GLP-1 without diet and lifestyle changes, and highly encourages exercise or Emsculpt NEO. Patients should never stop a GLP-1 suddenly: following a slow taper protocol is what makes patients successful.
GLP-1 medications are relatively new and research is ongoing. Working with a physician means you’re monitored for any potential risks.
It depends on the medical diagnosis: the medication may be covered or partially covered. Many patients don’t get coverage, but there are support programs that can help reduce the cost.
Book a consultation to discuss your goals and health history. The team will create a personalized plan and support you every step of the way.
This page is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any new treatment.